(Q31891288)

4 July 2017

title

The role of patient training in the management of seasonal rhinitis and asthma: clinical implications (English)

1 reference

4 July 2017

1 reference

Gani F

1

1 reference

4 July 2017

Pozzi E

2

1 reference

4 July 2017

Crivellaro MA

3

1 reference

4 July 2017

Senna G

4

1 reference

4 July 2017

Landi M

5

1 reference

4 July 2017

Lombardi C

6

1 reference

4 July 2017

Canonica GW

7

1 reference

4 July 2017

Passalacqua G

8

1 reference

4 July 2017

language of work or name

1 reference

1 January 2001

1 reference

4 July 2017

1 reference

4 July 2017

volume

56

1 reference

4 July 2017

issue

1

1 reference

4 July 2017

page(s)

65-68

1 reference

Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee

4 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00794.X

Changing prevalence of allergic rhinitis and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00794.X

Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00794.X

Continuous versus on demand treatment with cetirizine for allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00794.X

The impact of allergic rhinitis on bronchial asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00794.X

Treatment of allergic rhinitis with intranasal corticosteroids in patients with mild asthma: effect on lower airway responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00794.X

Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00794.X

Allergic rhinobronchitis: the asthma-allergic rhinitis link

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00794.X

The inflammatory nature of allergic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00794.X

7 January 2021

Continuous antihistamine treatment controls allergic inflammation and reduces respiratory morbidity in children with mite allergy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00794.X

7 January 2021

Nasal beclomethasone prevents the seasonal increase in bronchial responsiveness in patients with allergic rhinitis and asthma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00794.X

7 January 2021

Mometasone furoate. A review of its intranasal use in allergic rhinitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00794.X

7 January 2021

Minimal persistent inflammation is also present in patients with seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00794.X

7 January 2021

Once daily intranasal fluticasone propionate (200 micrograms) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00794.X

7 January 2021

10.1034/J.1398-9995.2001.00794.X

Identifiers

DOI

1 reference

4 July 2017

1 reference